Literature DB >> 24416050

Asymptomatic moyamoya syndrome, atlantoaxial subluxation and basal ganglia calcification in a child with Down syndrome.

Kyung Yeon Lee1, Kun-Soo Lee2, Young Cheol Weon3.   

Abstract

Down syndrome, the most common chromosomal abnormality, may be associated with various neurologic complications such as moyamoya syndrome, cervical spinal cord compression due to atlantoaxial subluxation, and basal ganglia damage, as well as epileptic seizures and stroke. Many cases of Down syndrome accompanied by isolated neurologic manifestations have been reported in children; however, Down syndrome with multiple neurologic conditions is rare. Here, we have reported a case of Down syndrome in a 10-year-old girl who presented with asymptomatic moyamoya syndrome, atlantoaxial subluxation with spinal cord compression, and basal ganglia calcification. To the best of our knowledge, this is the first report of Down syndrome, in a child, which was accompanied by these 3 neurologic complications simultaneously. As seen in this case, patients with Down syndrome may have neurologic conditions without any obvious neurologic symptoms; hence, patients with Down syndrome should be carefully examined for the presence of neurologic conditions.

Entities:  

Keywords:  Atlantoaxial instability; Basal ganglia calcification; Down syndrome; Moyamoya disease

Year:  2013        PMID: 24416050      PMCID: PMC3885790          DOI: 10.3345/kjp.2013.56.12.540

Source DB:  PubMed          Journal:  Korean J Pediatr        ISSN: 1738-1061


  16 in total

1.  Are Down syndrome patients predisposed to Moyamoya disease?

Authors:  Y Fukushima; Y Kondo; Y Kuroki; S Miyake; H Iwamoto; K Sekido; K Yamaguchi
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

Review 2.  Toward a molecular understanding of Down syndrome.

Authors:  J R Korenberg
Journal:  Prog Clin Biol Res       Date:  1993

3.  Basal ganglia calcification (BGC) in Down's syndrome (DS)--another manifestation of premature aging.

Authors:  K E Wisniewski; J H French; J F Rosen; P B Kozlowski; M Tenner; H M Wisniewski
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 4.  Early-onset Moyamoya syndrome in a patient with Down syndrome: case report and review of the literature.

Authors:  A I Dai; Z A Shaikh; M E Cohen
Journal:  J Child Neurol       Date:  2000-10       Impact factor: 1.987

5.  Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease.

Authors:  M Nordström; T Kjellström
Journal:  Atherosclerosis       Date:  1992-06       Impact factor: 5.162

Review 6.  Spine concerns in the Special Olympian with Down syndrome.

Authors:  James Channing Tassone; Allison Duey-Holtz
Journal:  Sports Med Arthrosc Rev       Date:  2008-03       Impact factor: 1.985

7.  Basal ganglia calcification and psychosis in Down's syndrome.

Authors:  M E Thase
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

8.  Cervical-spine instability in children with Down syndrome (trisomy 21).

Authors:  A A Semine; A N Ertel; M J Goldberg; M J Bull
Journal:  J Bone Joint Surg Am       Date:  1978-07       Impact factor: 5.284

9.  Interferon-gamma inhibits arterial stenosis after injury.

Authors:  G K Hansson; J Holm
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

10.  Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic, and clinical studies.

Authors:  S M Pueschel; F H Scola
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

View more
  2 in total

1.  Postintravenous immunoglobulin stroke in a toddler with Down syndrome: a diagnostic challenge.

Authors:  Teck-Hock Toh; Everlyn Coxin Siew; Chae-Hee Chieng; Hussain Imam Mohd Ismail
Journal:  BMJ Case Rep       Date:  2020-05-18

Review 2.  A Better Understanding of Moyamoya in Trisomy 21: A Systematic Review.

Authors:  Arowa Abdelgadir; Hamna Akram; Maurice H Dick; Nabeel R Ahmed; Abanti Chatterjee; Sushil Pokhrel; Vaishnavi Vaijaya Kulkarni; Safeera Khan
Journal:  Cureus       Date:  2022-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.